1. American Academy of Pediatrics. (1996). Health supervision for children with fragile X syndrome. Pediatrics, 98, 297–300.
2. Bardoni, B., Mandel, J. L., & Fisch, G. S. (2000). FMR1 gene and fragile X syndrome. American Journal of Medical Genetics (Seminars in Medical Genetics), 97, 153–163.
3. Berry-Kravis, E., Sumis, A., Hervey, C., et al. (2012). Clinic-based retrospective analysis of psychopharmacology for behavior in fragile X syndrome. International Journal of Pediatrics, 2012, 1–81.
4. Brown, W. T. (1995). Perspectives and molecular diagnosis of the fragile X syndrome. Clinics in Laboratory Medicine, 15, 859–875.
5. Brown, S. S. G., & Stanfield, A. C. (2015). Fragile X premutation carriers: A systematic review of neuroimaging findings. Journal of the Neurological Sciences, 352, 19–28.